The IRRDC team
The IRRDC fosters global collaboration between patients, families, physicians and scientists. Our main goal is to investigate causes, implement clinical management and develop novel treatments for children and adults with Lynch Syndrome, Constitutional Mismatch Repair Deficiency (CMMRD), and polymerase proofreading deficient cancer syndromes.
The consortium includes more than 200 members from 45+ countries, and is constantly growing.
Members of the IRRDC at our Annual RRD Workshop in 2017.
The governance committee